Overview, Pathogenesis and Medicinal Plant Used for Treatment of Vitiligo [PDF]
, 2023 The condition known as vitiligo results in the death of melanocytes. This destruction is caused by three main factors. It is estimated that 0.5% to 2% of people world wide suffer from vitiligo, a prevalent cutaneous disorder that causes ...
Ramya M, Kamaraj R, Shalini K
core +1 more source
Temporary improvement of porokeratotic inflammatory linear verrucous epidermal nevus with fractionated CO2 laser resurfacing [PDF]
Inflammatory linear verrucous epidermal nevus is a rare benign epidermal nevus that classically presents in childhood with pruritic, linear, erythematous, scaly coalescing papules and plaques distributed along the lines of Blaschko.
Bravo, Alexander +2 more
core +1 more source
Ruxolitinib in the Treatment of Vitiligo. The Importance of the JAK STAT Pathway
Actas Dermo-SifiliográficasVitiligo is a chronic autoimmune disease of multifactorial nature that causes skin depigmentation as a consequence of melanocyte loss. Although sometimes it is said to be untreatable, there are therapies that have succeeded in halting its progression and
J.L. López Estebaranz +2 more
doaj +1 more source
Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream [PDF]
, 2021 Andrew Blauvelt +10 more
openalex +1 more source
Dermatology ReportsDear Editor, A 50-year-old Caucasian male presented with a 30-year history of facial vitiligo, primarily affecting the chin and the perioral and periorbital regions. He had undergone multiple treatments over the years, including targeted phototherapy,
Andrea Bassi +5 more
doaj +1 more source
A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser [PDF]
Alopecia areata (AA) is an autoimmune disease that causes recurrent hair loss. No treatment has been effective in the long term because of the unstable efficacy and possible side effects.
Kabashima, Kenji +4 more
core +1 more source
Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy [PDF]
, 2023 Eric L. Simpson +7 more
openalex +1 more source
A Review of Biologic Therapies for Refractory Atopic Dermatitis [PDF]
Atopic Dermatitis (AD) is one of the most common skin conditions, affecting approximately 10% of all individuals in the United States. Existing therapies for AD include emollients, moisturizers, topical corticosteroids, phototherapy, and more.
Bogert, Camryn
core +1 more source
Role of Janus kinase Inhibitors (JAKis) in Autoimmune Disorders: Review [PDF]
JAK inhibitors (JAKis) comprise a crucial therapeutic tool for managing patients with immune-mediated inflammatory disorders. Although often perceived as a uniform class of medications thought to be largely interchangeable, notable variances exist in ...
H. Shehata, Lamia +2 more
core +2 more sources
Frontiers in PharmacologyWe performed a Bayesian network meta-analysis to indirectly compare the relative efficacy and safety of the latest JAK inhibitors for moderate-to-severe alopecia areata (AA). 13 trials totaling 3,613 patients were included.
Ting Yan +6 more
doaj +1 more source